View in EDS HTML Full Text PDF Full Text

Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway.

Saved in:
Bibliographic Details
Title: Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway.
Authors: Zhang, Ying1,2 (AUTHOR) zyts2008@126.com, Li, Can3 (AUTHOR), Li, Xiuqi1 (AUTHOR), Wu, Cheng2 (AUTHOR), Zhou, Haiyan4 (AUTHOR), Lu, Shuang3 (AUTHOR), Liu, Xingde5 (AUTHOR) 2360040895@qq.com
Source: Molecular Medicine Reports. Sep2020, Vol. 22 Issue 3, p2174-2182. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17912997
DOI:10.3892/mmr.2020.11309